Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of SV40 siRNA Vectors to Treat CML

NCT00257647 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00257647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00257647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of SV40 siRNA Vectors to Treat CML
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Completed
Start date
September 30, 2005
Completion date
November 30, 2007
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia